UPI reports people sickened with COVID-19 produce "high-quality" antibodies. The antibodies work against the virus five to seven months after they become infected. The findings suggest those infected with COVID-19 potentially can develop a long-lasting immunity to it. Antibodies are proteins produced by the human immune system to help the body fight off viruses. Many concerns have been expressed about immunity against COVID-19 not lasting.
A new, rapid, bedside test for COVID-19 delivers results in less than two hours. UPI reports a new study says such a quick turnaround means appropriate treatment can start earlier for those already hospitalized because of their symptoms. The standard COVID-19 test swabs the patient's nose and uses polymerase chain reaction, or PCR, technology. It typically takes over 20 hours to produce results.
New research from Harvard and Calgary Universities have shed new light on who is more or less likely to observe COVID-19 social distancing guidelines. UPI reports more North American and European men, and young adults of both sexes, fail to adhere to COVID-19 social distancing guidelines than older adults. The data showed 59% of male respondents said they adhered to local social distancing guidelines, while 69% of female respondents reported doing so.
During the 2019-20 flu season, 52% of people in the US were vaccinated against the seasonal influenza. And results of a new survey by the National Foundation for Infectious Diseases are likely to have public health officials cheering. UPI reports that of the 1,000 people surveyed, 60% of people in the United States plan to be vaccinated against the flu this winter. Nearly half said they were concerned about the potential effects of the novel coronavirus COVID-19 on the seasonal bug.
A new landmark study at the University of Maryland School of Medicine found that COVID-19 patients taking a daily, low-dose aspirin to protect against cardiovascular disease significantly lowered the..